Vivo Capital IX, LLC, 10% Owner at Tarsus Pharmaceuticals, Inc. (TARS), sold 201,620 shares at $29.70 ($5.9M) on 2021-06-21, disclosed to the SEC on 2021-06-25.
Open-market sale of $5.9M TARS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.70 | 91,620 | $2.7M | 46.5% |
| 2 | $28.50 | 110,000 | $3.1M | 53.5% |
| Total | $29.05 avg | 201,620 | $5.9M | 100% |
| Filing → |
| TARS | SELL | 2021-06-25 | $1.9M | — | Filing → |
| TARS | SELL | 2021-04-16 | $12K | — | Filing → |